撰写医学文献常用英语.docVIP

identically designed，phase3，placebo-controlled trials设计相同的Ⅲ期、安慰剂对照试验 were followed for an additional 10days 并接受额外10天的随访 follow-up 随访 primary outcome 主要转归 rritable bowel syndrome IBS肠易激综合征 as compared with 相比之下 rifaximin 利福昔明 hazard ratio 风险比为 acute otitis media 急性中耳炎 adjusted odds ratio 经校正的比值比 asthma 哮喘 confidence interval 可信区间（CI）为 chemotherapy 化疗 exceed 超过 initial 最初 inhibitory activity 抑制活性 evidence suggests that 有证据表明 heparin 肝素 an open-label，phase2 开放标签2期 catheter-locking regimen 封管方案 were randomly assigned 被随机分配接受 cardiac arrest 心脏停搏 the primary end point 主要终点 EMS急救医疗服务 key secondary end point 关键的次要终点 Newborn screening 新生儿筛查 1% vs02% 1% 对02% Preterm Infants 早产儿 Daily ratings of 每日分级 tidal volumes. 潮气量 The incidence of adverse events 不良事件发生率 inspiratory and expiratory 吸气和呼气 Initial resolution of symptoms 最初症状消失 vital capacity 肺活量 Corresponding values 对应值 pro-drug前体药物 The rate of clinical failure 临床失败率 active metabolite 活性代谢物 The first dose 首剂 metabolism新陈代谢 The end-of-treatment visit 治疗结束随访 particle颗粒 The rate of Objective response 客观有效率 metered dose inhaler定量雾化吸入器(MDI The rate of clinical benefit 临床获益率 Resuscitation复苏 Progression free survival 无进展生存期 second-tier therapy二线治疗 Case Control Study对照应用研究 superior and inferior vena cava 上腔和下腔静脉 Reversible form 可逆类型 critically ill patients 危重症患者 A prospective cohort study 前瞻性队列研究 pulmonary edema 肺水肿 Intention –to-treat analysis 意向治疗分析 beta-blocking agents ?受体阻断剂 Two cross-sectional studies 2项横断面研究 under-diagnosed 漏诊 randomised controlled trials (RCT)随机对照试验 the cause and consequences 因果 Median 中位数 ventricular systolic or diastolic dysfunction 心室收缩和舒张